China Plasma Protease C1-inhibitor Treatment Market Research Report 2017

December 2017 | 102 pages | ID: C6A8AF2F3ACEN
QYResearch

Abstracts

The global Plasma Protease C1-inhibitor Treatment market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Plasma Protease C1-inhibitor Treatment development status and future trend in China, focuses on top players in China, also splits Plasma Protease C1-inhibitor Treatment by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Shire plc
• CSL Limited
• Sanquin
• Pharming Group N.V.

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• by Drug Class
• C1-inhibitors
• Kallikrein Inhibitor (Kalbitor)
• Selective Bradykinin B2 Receptor Antagonist (Firazyr)
• by Dosage Type
• Liquid/Injectable
• Lyophilized

On the basis of the end users/application, this report covers

• Hospital Pharmacies
• Independent Pharmacies and Outlets

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Plasma Protease C1-inhibitor Treatment Market Research Report 2017

1 PLASMA PROTEASE C1-INHIBITOR TREATMENT OVERVIEW

1.1 Product Overview and Scope of Plasma Protease C1-inhibitor Treatment
1.2 Classification of Plasma Protease C1-inhibitor Treatment by Product Category
  1.2.1 China Plasma Protease C1-inhibitor Treatment Sales (K Units) Comparison by Type (2012-2022)
  1.2.2 China Plasma Protease C1-inhibitor Treatment Sales (K Units) Market Share by Type in 2016
  1.2.3 C1-inhibitors
  1.2.4 Kallikrein Inhibitor (Kalbitor)
  1.2.5 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
1.3 China Plasma Protease C1-inhibitor Treatment Market by Application/End Users
  1.3.1 China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Independent Pharmacies and Outlets
1.4 China Plasma Protease C1-inhibitor Treatment Market by Region
  1.4.1 China Plasma Protease C1-inhibitor Treatment Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
  1.4.3 East China Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
  1.4.4 Southwest China Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
  1.4.5 Northeast China Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
  1.4.6 North China Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
  1.4.7 Central China Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Plasma Protease C1-inhibitor Treatment (2012-2022)
  1.5.1 China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%)(2012-2022)
  1.5.2 China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Plasma Protease C1-inhibitor Treatment Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Plasma Protease C1-inhibitor Treatment Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Plasma Protease C1-inhibitor Treatment Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Plasma Protease C1-inhibitor Treatment Market Competitive Situation and Trends
  2.4.1 China Plasma Protease C1-inhibitor Treatment Market Concentration Rate
  2.4.2 China Plasma Protease C1-inhibitor Treatment Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Plasma Protease C1-inhibitor Treatment Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA PLASMA PROTEASE C1-INHIBITOR TREATMENT SALES AND REVENUE BY REGION (2012-2017)

3.1 China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Plasma Protease C1-inhibitor Treatment Price (USD/Unit) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Plasma Protease C1-inhibitor Treatment Price (USD/Unit) by Type (2012-2017)
4.4 China Plasma Protease C1-inhibitor Treatment Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Plasma Protease C1-inhibitor Treatment Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA PLASMA PROTEASE C1-INHIBITOR TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Shire plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire plc Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CSL Limited
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CSL Limited Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanquin
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pharming Group N.V.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview

7 PLASMA PROTEASE C1-INHIBITOR TREATMENT MANUFACTURING COST ANALYSIS

7.1 Plasma Protease C1-inhibitor Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Plasma Protease C1-inhibitor Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Type (2017-2022)
11.3 China Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Application (2017-2022)
11.4 China Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Plasma Protease C1-inhibitor Treatment Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application (2016-2022)
Figure Product Picture of Plasma Protease C1-inhibitor Treatment
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Market Share by Types in 2016
Figure C1-inhibitors Product Picture
Figure Kallikrein Inhibitor (Kalbitor) Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Picture
Figure China Plasma Protease C1-inhibitor Treatment Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Plasma Protease C1-inhibitor Treatment by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Independent Pharmacies and Outlets Examples
Table Key Downstream Customer in Independent Pharmacies and Outlets
Figure South China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Plasma Protease C1-inhibitor Treatment Sales of Key Players/Manufacturers (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Plasma Protease C1-inhibitor Treatment Sales Share (%) by Players/Manufacturers
Figure 2017 China Plasma Protease C1-inhibitor Treatment Sales Share (%) by Players/Manufacturers
Table China Plasma Protease C1-inhibitor Treatment Revenue by Players/Manufacturers (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) by Players/Manufacturers
Table China Market Plasma Protease C1-inhibitor Treatment Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Plasma Protease C1-inhibitor Treatment Average Price of Key Players/Manufacturers in 2016
Figure China Plasma Protease C1-inhibitor Treatment Market Share of Top 3 Players/Manufacturers
Figure China Plasma Protease C1-inhibitor Treatment Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Plasma Protease C1-inhibitor Treatment Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Plasma Protease C1-inhibitor Treatment Product Category
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) by Regions (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Sales Share (%) by Regions (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Share (%) by Regions (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Market Share (%) by Regions in 2016
Table China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) by Regions in 2016
Table China Plasma Protease C1-inhibitor Treatment Price (USD/Unit) by Regions (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Sales Share (%) by Type (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Share (%) by Type (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Market Share (%) by Type in 2016
Table China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Plasma Protease C1-inhibitor Treatment by Type (2012-2017)
Figure Revenue Market Share of Plasma Protease C1-inhibitor Treatment by Type in 2016
Table China Plasma Protease C1-inhibitor Treatment Price (USD/Unit) by Types (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Growth Rate (%) by Type (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) by Applications (2012-2017)
Table China Plasma Protease C1-inhibitor Treatment Sales Market Share (%) by Applications (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Market Share (%) by Application (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Market Share (%) by Application in 2016
Table China Plasma Protease C1-inhibitor Treatment Sales Growth Rate (%) by Application (2012-2017)
Figure China Plasma Protease C1-inhibitor Treatment Sales Growth Rate (%) by Application (2012-2017)
Table Shire plc Plasma Protease C1-inhibitor Treatment Basic Information List
Table Shire plc Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Shire plc Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Shire plc Plasma Protease C1-inhibitor Treatment Sales Market Share (%) in China (2012-2017)
Figure Shire plc Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) in China (2012-2017)
Table CSL Limited Plasma Protease C1-inhibitor Treatment Basic Information List
Table CSL Limited Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure CSL Limited Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure CSL Limited Plasma Protease C1-inhibitor Treatment Sales Market Share (%) in China (2012-2017)
Figure CSL Limited Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) in China (2012-2017)
Table Sanquin Plasma Protease C1-inhibitor Treatment Basic Information List
Table Sanquin Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Sanquin Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Sanquin Plasma Protease C1-inhibitor Treatment Sales Market Share (%) in China (2012-2017)
Figure Sanquin Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) in China (2012-2017)
Table Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Basic Information List
Table Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales Market Share (%) in China (2012-2017)
Figure Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protease C1-inhibitor Treatment
Figure Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
Figure Plasma Protease C1-inhibitor Treatment Industrial Chain Analysis
Table Raw Materials Sources of Plasma Protease C1-inhibitor Treatment Major Players/Manufacturers in 2016
Table Major Buyers of Plasma Protease C1-inhibitor Treatment
Table Distributors/Traders List
Figure China Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Market Share Forecast by Type in 2022
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Application (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Market Share Forecast by Application in 2022
Table China Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Regions (2017-2022)
Table China Plasma Protease C1-inhibitor Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources